{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:49:14Z","timestamp":1791492554206,"version":"4.3.4"},"reference-count":38,"publisher":"American Society of Clinical Oncology (ASCO)","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["J Clin Oncol"],"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Desmoid tumors (DTs) are rare, often locally aggressive, connective tissue neoplasms with limited effective treatment options. We evaluated the safety and efficacy of varegacestat, an oral gamma-secretase inhibitor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>RINGSIDE phase II was an open-label, randomized, dose-finding trial of varegacestat in adults with histologically confirmed DT and disease progression. Participants were randomly assigned 1:1:1 to oral varegacestat 1.2-mg once-daily, 2-mg intermittent (once daily for 2 consecutive days with 5 consecutive days off), or 4-mg intermittent dose. The primary end point was safety. The secondary end point was change in tumor volume from baseline to week 16 per blinded independent central review. At the study end, participants who entered the open-label extension received the selected phase III dose (1.2 mg once daily).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>In total, 42 participants enrolled in the randomized trial (14 per dose arm). Median varegacestat exposure was 50.5 (range, 3.0-76.0) weeks. Forty-one (97.6%) participants reported treatment-related adverse events (AEs), of which 9 (21.4%) reported grade 3 AEs and none reported serious AEs. There were no grade 4\/5 events. The median tumor volume reduction at week 16 was \u201351.91% for the 1.2-mg once-daily dose, \u201315.25% for the 2-mg intermittent dose and \u20139.50% for the 4-mg intermittent dose. The confirmed objective response rate (ORR) was 35.7%, 21.4%, and 21.4%, respectively. Among 29 (69%) participants who entered the open-label extension and received 1.2 mg once daily (median exposure, 102.0 [range, 3.0-169.0] weeks), the median best percent tumor volume change was \u201385.88% and the confirmed ORR increased to 57.1%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Varegacestat demonstrated clinically meaningful DT volume reduction and ORR with a manageable safety profile across dose regimens. The largest responses were seen with the 1.2-mg once-daily dose, which was selected for the RINGSIDE phase III trial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco-26-00725","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:59:06Z","timestamp":1791489546000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Finding Clinical Trial"],"prefix":"10.1200","clinical-trial-number":[{"clinical-trial-number":"nct04871282","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-6971","authenticated-orcid":false,"given":"Rashmi","family":"Chugh","sequence":"first","affiliation":[{"name":"University of Michigan Rogel Comprehensive Cancer Center, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Singh","sequence":"additional","affiliation":[{"name":"University of California Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1938-875X","authenticated-orcid":false,"given":"Vladimir","family":"Andelkovic","sequence":"additional","affiliation":[{"name":"Princess Alexandra Hospital and Icon Cancer Centre, South Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2490-3004","authenticated-orcid":false,"given":"Atrayee Basu","family":"Mallick","sequence":"additional","affiliation":[{"name":"Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8854-0372","authenticated-orcid":false,"given":"Bruce","family":"Brockstein","sequence":"additional","affiliation":[{"name":"Endeavor Health Cancer Institute, Evanston, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-4349","authenticated-orcid":false,"given":"Nam","family":"Bui","sequence":"additional","affiliation":[{"name":"Stanford Health Care, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sant","family":"Chawla","sequence":"additional","affiliation":[{"name":"Sarcoma Oncology Center, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9896-8084","authenticated-orcid":false,"given":"Edwin","family":"Choy","sequence":"additional","affiliation":[{"name":"Mass General Brigham Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6480-1611","authenticated-orcid":false,"given":"Lara E.","family":"Davis","sequence":"additional","affiliation":[{"name":"Oregon Health &amp; Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8468-0119","authenticated-orcid":false,"given":"Mrinal","family":"Gounder","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2837-5846","authenticated-orcid":false,"given":"Shadi","family":"Haddadin","sequence":"additional","affiliation":[{"name":"Jefferson City Medical Group, Jefferson City, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8425-8356","authenticated-orcid":false,"given":"Bernd","family":"Kasper","sequence":"additional","affiliation":[{"name":"Mannheim University Medical Center, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0625-9828","authenticated-orcid":false,"given":"Hyo Song","family":"Kim","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2976-6811","authenticated-orcid":false,"given":"Alexander","family":"Lee","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4305-117X","authenticated-orcid":false,"given":"Jeremy","family":"Lewin","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5864-762X","authenticated-orcid":false,"given":"Nadia","family":"Hindi","sequence":"additional","affiliation":[{"name":"Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9871-4463","authenticated-orcid":false,"given":"Prabhjot","family":"Mundi","sequence":"additional","affiliation":[{"name":"Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4914-7922","authenticated-orcid":false,"given":"Ravin","family":"Ratan","sequence":"additional","affiliation":[{"name":"University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7549-3338","authenticated-orcid":false,"given":"Winette","family":"van der Graaf","sequence":"additional","affiliation":[{"name":"Netherlands Cancer Institute, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Yoon","sequence":"additional","affiliation":[{"name":"City of Hope Comprehensive Cancer Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Birrenkott","sequence":"additional","affiliation":[{"name":"Immunome, Bothell, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Fetterly","sequence":"additional","affiliation":[{"name":"Immunome, Bothell, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Newhall","sequence":"additional","affiliation":[{"name":"Immunome, Bothell, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Song","sequence":"additional","affiliation":[{"name":"Immunome, Bothell, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Yovell","sequence":"additional","affiliation":[{"name":"Immunome, Bothell, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4173-3844","authenticated-orcid":false,"given":"Robin L.","family":"Jones","sequence":"additional","affiliation":[{"name":"The Royal Marsden NHS Foundation Trust + Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the RINGSIDE Phase II Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Andelkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Brockstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sant","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Chugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal","family":"Gounder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Haddadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Hindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Song","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atrayee","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier Martin","family":"Broto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhjot","family":"Mundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravin","family":"Ratan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winette","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Van Tine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"e_1_3_10_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.1805"},{"key":"e_1_3_10_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000374"},{"key":"e_1_3_10_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.8482"},{"key":"e_1_3_10_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030709"},{"key":"e_1_3_10_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5985"},{"key":"e_1_3_10_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14122979"},{"key":"e_1_3_10_8_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.080475"},{"key":"e_1_3_10_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-015-0306-2"},{"key":"e_1_3_10_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.11.005"},{"key":"e_1_3_10_11_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21293"},{"key":"e_1_3_10_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29564"},{"key":"e_1_3_10_13_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0809"},{"key":"e_1_3_10_14_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.3280"},{"key":"e_1_3_10_15_2","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/64000"},{"key":"e_1_3_10_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34332"},{"key":"e_1_3_10_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00308-1"},{"key":"e_1_3_10_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2013.06.005"},{"key":"e_1_3_10_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.09.005"},{"key":"e_1_3_10_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29562"},{"key":"e_1_3_10_21_2","volume-title":"Nirogacestat (Ogsiveo) Tablets, for Oral Use. Prescribing Information. SpringWorks Therapeutics, Inc","year":"2024","unstructured":"Nirogacestat (Ogsiveo) Tablets, for Oral Use. Prescribing Information. SpringWorks Therapeutics, Inc: Stamford, CT, 2024"},{"key":"e_1_3_10_22_2","volume-title":"Summary of Product Characteristics","author":"Nirogacestat (Ogsiveo) tablets for oral use","year":"2025","unstructured":"Nirogacestat (Ogsiveo) tablets for oral use: Summary of Product Characteristics. SpringWorks Therapeutics Ireland Limited, Dublin, Ireland, 2025"},{"key":"e_1_3_10_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2210140"},{"key":"e_1_3_10_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805052"},{"key":"e_1_3_10_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-018-0597-6"},{"key":"e_1_3_10_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-016-2439-y"},{"key":"e_1_3_10_27_2","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.2021210016"},{"key":"e_1_3_10_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1286807"},{"key":"e_1_3_10_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.615986"},{"key":"e_1_3_10_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2819"},{"key":"e_1_3_10_31_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00005.2017"},{"key":"e_1_3_10_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.2194"},{"key":"e_1_3_10_33_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.939167"},{"key":"e_1_3_10_34_2","doi-asserted-by":"publisher","DOI":"10.1530\/REP-16-0689"},{"key":"e_1_3_10_35_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0281"},{"key":"e_1_3_10_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.02.008"},{"key":"e_1_3_10_37_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1177"},{"key":"e_1_3_10_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq341"},{"key":"e_1_3_10_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30276-1"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO-26-00725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:59:07Z","timestamp":1791489547000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO-26-00725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":38,"alternative-id":["10.1200\/JCO-26-00725"],"URL":"https:\/\/doi.org\/10.1200\/jco-26-00725","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"2026-03-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"JCO-26-00725"}}